Romina Luca

Patients with Colorectal Cancer and BRAFV600E-Mutation in Argentina: A Real-World Study—The EMOGI-CRC01 Study

Greta Catani, Stéfano Kim, Federico Waisberg, Diego Enrico et autres

Background/Objectives: The BRAF-mutation is a poor prognostic factor in colorectal cancer (CRC). There is a need for real-world data in low-middle-income countries regarding clinical characteristics, outcomes, and treatment strategies. This study aims to describe progression-free survival (PFS) and in the first- and …

ar, fr (code pays fourni par la source)

Implementation of an Educational Intervention for Gastric Cancer Awareness in the General Population in CELAC and Europe: A Strategy Proposed by the LEGACy Consortium

Juan Antonio Carbonell‐Asins, Elena Jiménez-Martí, Sergio Romero, Eduardo García et autres

Gastric cancer (GC) has a poor prognosis. The LEGACy consortium has been established to enhance GC outcomes though improved primary and secondary prevention strategies. We performed an educational intervention study using an online module to disseminate knowledge about GC risk factors and …

es, py, mx, pt, nl, ar, cl (code pays fourni par la source)

Patients with Colorectal Cancer and BRAFV600E-Mutation in Argentina: A Real-World Study: The EMOGI-CRC01 Study

Greta Catani, Stéfano Kim, Federico Waisberg, Diego Enrico et autres

Background/Objectives: BRAF-mutation is a poor prognostic factor in colorectal cancer (CRC). There is a need for real-world data in low-middle-income countries regarding clinical characteristics, outcomes, and treatment strategies. This study aims to describe progression free survival (PFS) and overall survival (OS) in …

ar, uy (code pays fourni par la source)

Implementation of an Educational Intervention for Gastric Cancer Awareness in the General Population in CELAC and Europe. A Strategy Proposed by the LEGACy Consortium

Juan Antonio Carbonell‐Asins, Elena Jiménez-Martí, Sergio Romero, Eduardo García‐Galea et autres

us, es, py, mx, pt, nl, ar (code pays fourni par la source)

Implementation of an Educational Intervention for Gastric Cancer Awareness in the General Population in Celac and Europe. A Strategy Proposed by the Legacy Consortium

Tania Fleitas, Juan Antonio Carbonell‐Asins, Elena Jiménez-Martí, Sergio Romero et autres

us, es, py, mx, pt, nl, ar (code pays fourni par la source)

Argentinian registry of gastric neuroendocrine tumors: A closer look at type 1

Ana Oviedo, Romina Luca, Claudia Bestani, Andrés Rodrı́guez et autres

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Clinical and genomic characterization of pancreatic ductal adenocarcinoma patients with lung oligometastasis

Natalia Soledad Tissera, Marta Chiaravalli, Anthony Turpin, Romina Luca et autres

Lung-only relapse following resection of pancreatic ductal adenocarcinoma (PDAC) is rare. While oligometastatic lung disease (OMLD) is detected after PDAC resection, its clinical and molecular features remain unclear. Our goal was to assess if lung metastatic lesion quantity and mutations could predict …

es, it, fr, ar (code pays fourni par la source)

Influence of proton pump inhibitors on the pathological response of rectal cancer: a multicentre study

Marcelle Goldner Cesca, Erika Ruíz‐García, Rui Weschenfelder, Nathalia D’Agustini et autres

Background: The standard neoadjuvant therapy for rectal cancer involves fluoropyrimidines and radiotherapy and, most recently, total neoadjuvant therapy (TNT).A drug-drug interaction between fluoropyrimidines and proton-pump inhibitors (PPI) was suggested, with a negative impact on oncological outcomes in breast, colon and gastric cancers.Little …

br, mx, ar (code pays fourni par la source)

Short-course radiotherapy for rectal cancer: real-world evidence in Argentina

Natalia Soledad Tissera, Berenice Freile, Federico Waisberg, Federico Esteso et autres

Background: Short-course radiotherapy (SCRT) of 25 Gy in five daily fractions is a recommended strategy in the neoadjuvant setting for resectable locally advanced rectal cancer (LARC), as well as in cases of metastatic disease for local control.There is scarce information regarding the …

us, es, ar (code pays fourni par la source)

Atypical pattern of response in rectal cancer after neoadjuvant pembrolizumab treatment: a case report, literature review, and proposed management model

Natalia Soledad Tissera, Federico Esteso, Romina Luca, Diego Enrico et autres

Background: Immunotherapy is the first-line treatment in patients with advanced microsatellite instability-high (MSI-H) or deficient mismatch repair (dMMR) colorectal cancer (CRC). Although immune checkpoint inhibitors (ICIs) for locally advanced rectal cancer (LARC) are not yet a standard, the results are very encouraging …

es, ar (code pays fourni par la source)

P-201 First large cohort in Latin America of CCR BRAF V600E mutated. Real world data

Gualtiero Catani, Romina Luca, Alexander Araya Oviedo, Luisina Bruno et autres

ar (code pays fourni par la source)

P-290 Treatment sequences and locoregional therapies for patients with carcinoid and refractory carcinoid syndrome. A multicentric cohort analysis

Alexander Araya Oviedo, Romina Luca, Andrés Rodríguez, Federico Waisberg et autres

ar (code pays fourni par la source)